Back to search results

Automated Sleep Monitor for Alzheimer's and Dementia Patients

This study is looking at how well a Non-Contact Sleep Quality Monitor System works for people with Alzheimer's disease (AD) or related dementias (ADRD) who live in long-term care facilities. The goal is to see if sharing the sleep data from this device with caregivers and medical staff helps them identify and treat sleep problems better. You would use the sleep monitor for four weeks. Researchers will compare how well sleep disorders are documented and if sleep quality improves when staff have access to the monitoring data versus when they don't. The study aims to enroll 100 participants. Currently, the study's recruitment status is unclear.

Study design
This is a before-after comparison trial conducted in several long-term care facilities, involving 100 planned participants.
What's involved
You would use a non-contact sleep monitoring device for a total of four weeks.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, documentation of sleep disorders or treatment, is measured at 4-weeks, which is the duration of the monitoring.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06045988

Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's Disease

Not Yet Recruiting
NAAges 18+InterventionalDiagnostic
Indiana University
~100 participants
Updated 2026-06-26 on ClinicalTrials.gov
What's tested:Non-Contact Sleep Quality Monitor System

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Documentation of sleep disorders or treatment
Measured over 4-weeks

Conditions

Alzheimer Disease
Dementia
Sleep Disturbance

Explore related trials

Alzheimer's DiseaseDementia

Where it's being run

1 sites across 1 states
Indiana1

Study leadership

  • Kathleen Unroe, MD, MHA, MS · PRINCIPAL_INVESTIGATOR · Indiana University

Who to contact

Kathleen Unroe, MD, MHA, MS
[email protected]
317-274-9227
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of Alzheimer's Disease (AD) or Alzheimer's Disease Related Dementias (ADRD)
Residents of long-term care (LTC) facility study site location for a minimum of 30 days.
Willingness to consent to study or when a potential participant lacks decision making capacity (determined by LTC facility clinical provider) willingness of a Legally Authorized Representative (LAR) to consent to study participation on potential participant's behalf.

Exclusion

Currently on hospice

What this trial measures

  • Documentation of sleep disorders or treatment4-weeks

    Primary outcome documentation of diagnosis, or evidence of treatment of sleep disorders, will be obtained through review of the medical record. Evidence of such a diagnosis or treatment could be indicated in nursing notes, physician notes, psychoactive or sedative medication changes, new ICD 10 sleep disorder diagnoses, medical orders for sleep studies or sleep medicine consults, all contained in the medical record.